|
As of 05/15/2017, over (b)(4) supercable iso-elastic cerclage implants have been used since product introduction in 2004.For the sternotomy closure indication, it is estimated that supercables have been used in over (b)(4) cases over the last 2 years, and this is the (b)(4) report of infection that kinamed has received.The supercable system has a long history of successful use with an extremely low adverse event rate.Inspection of the explanted supercable implants was not possible because they were not available for return and the cable and curved mini passer instrument lots involved in this event are depleted from our inventory.Review of the supercable cerclage system labeling confirms that the cautions and warnings relating to potential infection are appropriately described.The supercable's instructions for use (document (b)(4)) includes warnings about aseptic technique and recommended steps to avoid contamination.Review of the device history records and sterilization records for these lots of cerclage cables and the curved mini passer shows they were released with no deviations or non-conformances.Two of the cerclage cable lots were sterilized in the same load which has not resulted in any other known infections in the field.There are no radiographs or photos of the infected surgical site available for evaluation of this case.The supercable system has over 10 years of clinical experience in orthopedic applications, including in challenging cases that involved pre-existing infection (as summarized in several peer-reviewed publications), and approximately 2 years of clinical experience in sternotomy closure with no evidence of elevated infection risk.It is suspected that the root cause was not a result of any issue inherent to the cable system.The most likely root cause that the wound, the implant, or the instrumentation was somehow contaminated in the operating room, which is a general risk inherent to any surgical procedure and use of any surgical device.Not returned to manufacturer.
|